FamiCord

FamiCord Dettes/EBITDA

Ratio de la Dette Totale sur EBITDA de FamiCord (V3V.DE) au 3 nov. 2026 est -6,68. L'année précédente, Ratio de la Dette Totale sur EBITDA était -1,95 — une variation de 241,82 % (plus faible).

Dettes/EBITDA

-6,68

YoY

241,82%

Dernière mise à jour:

Ratio de la Dette Totale sur EBITDA de FamiCord est 2025 -6,68 . Ratio de la Dette Totale sur EBITDA de FamiCord était 2024 -1,95 . Elle diminue ainsi de 241,82% plus faible par rapport à l'année précédente.

L'histoire de FamiCord Dettes/EBITDA

  • 3 ans

  • 10 ans

  • 25 ans

  • Max

Dettes/EBITDA
Date
Dettes/EBITDA
1 janv. 2018
2,29 EUR
1 janv. 2019
1,82 EUR
1 janv. 2020
1,74 EUR
1 janv. 2021
-16,04 EUR
1 janv. 2022
-1,15 EUR
1 janv. 2023
-19,35 EUR
1 janv. 2024
-1,95 EUR
1 janv. 2025
-6,68 EUR
L'histoire de FamiCord Dettes/EBITDA
ANNÉEDettes/EBITDAYoY
-6,68+241,82%
-1,95-89,90%
-19,35+1 587,31%
-1,15-92,85%
-16,04-1 022,74%
1,74-4,47%
1,82-20,57%
2,29-83,51%
13,90+375,63%
2,92+102,96%
1,44+1 040,41%
0,13—

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

FamiCord Analyse d'actions

Que fait FamiCord ? Die Vita 34 AG is one of the leading companies in the field of stem cell technology. It was founded in 1997 in Leipzig and since then it has an impressive history. The company has focused its main attention on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include various services. For example, a package can be booked that only includes the storage of umbilical cord blood or another package that additionally includes the storage of umbilical cord tissue. But Vita 34 AG not only offers the possibility of storing stem cells, but also various additional services. For example, customers can also have genetic predisposition tests carried out. This can determine the risk of certain diseases. As a result, customers can take targeted preventive measures and, if necessary, consider other treatment options. Another important pillar of Vita 34 AG is the trade in stem cells. Through the storage of umbilical cord blood and tissue, the company builds up a comprehensive portfolio of stem cells that can then be sold to medical facilities as needed. The company works closely with doctors and research institutions to be able to use the stem cells effectively. Vita 34 AG is not only active in German-speaking countries. It also has branches in other countries, such as Austria, Switzerland, and the Netherlands. This allows it to operate internationally and respond to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage containers for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased here. Vita 34 AG has set itself the goal of increasing awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the aim is to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has made an impressive development in recent years. It is now internationally known and has established itself as a competent and reliable partner in stem cell technology. With its wide range of services and products, it is the first point of contact for many people when it comes to the storage of stem cells. Answer: Die Vita 34 AG ist eines der führenden Unternehmen im Bereich der Stammzelltechnologie und hat sich als kompetenter und zuverlässiger Partner etabliert. FamiCord est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action FamiCord

Ratio de la Dette Totale sur EBITDA de FamiCord s'élève à -6,68 en 2025.

Ratio de la Dette Totale sur EBITDA de FamiCord a changé de -1,95 à -6,68, ce qui représente une variation de 241,82 %. La valeur est plus faible qu'l'année précédente.

Sur Eulerpool, vous trouverez l'évolution historique complète de FamiCord de Ratio de la Dette Totale sur EBITDA depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

Dette/EBITDA mesure la dette totale par rapport au résultat avant intérêts, impôts, amortissements et dépréciations. Elle indique le nombre d'années nécessaires pour rembourser toute la dette à partir de l'EBITDA.

Un 'bon' varie selon le secteur et le stade de l'entreprise. Sur Eulerpool, vous pouvez comparer FamiCord de Ratio de la Dette Totale sur EBITDA avec les pairs du secteur et la moyenne du secteur pour évaluer son attrait.

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Endettement — FamiCord

Toutes les Métriques Clés — FamiCord

Croissance